CURRENT FUNDING

Unnumbered (Sutton): 3/2023 – 10/2024
Centers for Disease Control
Strengthening HAI/AR Program Capacity in Oregon
Advance state infrastructure and initiatives to track and limit the spread of healthcare-associated infections and antibiotic resistance.
Role: Co-Investigator/Sub-Award PI

U54TR002369 (Ellison and Morris): 7/2022 – 06/2027
National Center for Advancing Translational Sciences/NIH/DHHS
Oregon Clinical and Translational Research Institute (OCTRI)
The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at Oregon Health & Science University since 2006. Its many highly functional programs assist investigators and trainees by providing diverse services. The major goal of OCTRI is to foster research to find better treatments for disease and help find ways to keep people healthy. It is also focused on training the translational research workforce of the future. 
Role: Co-Director, TL1 Program 

PAST FUNDING

1 R03 HS026819- 01A1 (McGregor): 9/01/2019 – 8/31/2020
AHRQ
Evaluating antibiotic utilization metrics
Study aims to evaluate the CDC’s risk adjusted SAAR metric as a proxy for appropriate use of antibacterials.
Role: PI

IIR 17-039 (Suda): 7/01/2018 – 6/30/2022
VA HSR&D
Optimizing antibiotic prescribing on discharge to long-term care facilities
Study aims to identify opportunities for prescribing intervention and to understand the facilitators and barriers to implementing these interventions in acute care and long term care facilities.
Role: Co-Investigator

1 R01 HS026747- 01A1 (Furuno): 2/01/2019 – 1/31/2022
AHRQ
Optimizing antibiotic prescribing on discharge to long-term care facilities
Study aims to identify opportunities for prescribing intervention and to understand the facilitators and barriers to implementing these interventions in acute care and long term care facilities.
Role: Co-Investigator

1R01HS02517701A1 (Suda): 09/30/17-01/07/21
AHRQ
Dental prescribing of antibiotics and opioids: high use in the absence of evidence
Role: Co-Investigator

SMMI0235A, (Helfand): 01/01/16-12/31/21
PCORI
Peer Review of PCORI’s Funded Research
Contract provides infrastructure for the peer review and ultimate publication of final reports from all PCORI-funded contracts.
Role: Associate Editor

1 R01 HS022706 – 01A1 (McGregor): 9/30/2014 – 9/29/2018
AHRQ
Improving empiric therapy in ambulatory care
Study aims to develop risk score that can inform prudent and appropriate antibiotic selection for uncomplicated urinary tract infections in primary care settings
Role: Co-Investigator

000HCVLD-2016-03606 (Pakyz): 09/30/16-09/29/19
Centers for Disease Control and Prevention
Development of NHSN’s AUR data and SAAR to support Antibiotic Benchmarking Program among Vizient Members.
Role: Consortium PI

IFRA-0281 (Furuno): 01/06/17-01/06/19
Merck Sharp & Dohme Corp.
A Retrospective Cohort Study of the Benefits and Burdens of Preemptive Antiviral Therapy for CMV among Hematopoietic Stem Cell Transplant Patients
Role: Co-Investigator

HC-1510-06870 (Hartung): 10/01/16-09/30/18
National Multiple Sclerosis Society
Costs, Access, and Value of Multiple Sclerosis Disease-Modifying Therapies
Evidence generated from this study can be used by NMSS and other MS stakeholders better advocate for policies to mitigate problems associated with the high costs of DMTs in the US.
Role: Co-Investigator

Un-numbered (Tallman): 10/01/17-09/30/18
Society for Infectious Diseases Pharmacists
Epidemiology of Recurrent UTI in Female Outpatients
Role: Mentor/Co-Investigator